JP Morgan Maintains Overweight on Stryker, Lowers Price Target to $350
Benzinga Newsdesk 3 months ago
NewsPrice TargetAnalyst Ratings
JP Morgan analyst Robbie Marcus maintains Stryker (NYSE:SYK) with a Overweight and lowers the price target from $400 to $350.
JP Morgan analyst Robbie Marcus maintains Stryker (NYSE:SYK) with a Overweight and lowers the price target from $400 to $350.